1,2-dimethylhydrazine has been researched along with allopurinol in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Salim, AS | 1 |
| Chen, D; Fukunari, A; Hashimoto, T; Kato, N; Yamada, I; Yanaka, N | 1 |
2 other study(ies) available for 1,2-dimethylhydrazine and allopurinol
| Article | Year |
|---|---|
Removing oxygen-derived free radicals delays hepatic metastases and prolongs survival in colonic cancer. A study in the rat.
Topics: 1,2-Dimethylhydrazine; Allopurinol; Animals; Carcinogens; Colonic Neoplasms; Dimethyl Sulfoxide; Dimethylhydrazines; Free Radicals; Liver Neoplasms, Experimental; Male; Oxygen; Rats; Rats, Inbred Strains; Survival Analysis | 1992 |
Y-700, a novel inhibitor of xanthine oxidase, suppresses the development of colon aberrant crypt foci and cell proliferation in 1,2-dimethylhydrazine-treated mice.
Topics: 1,2-Dimethylhydrazine; Animals; Cell Proliferation; Colon; Colonic Diseases; Dose-Response Relationship, Drug; Male; Mice; Mice, Inbred Strains; Pyrazoles; Xanthine Oxidase | 2005 |